We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

A Phase 3 Study to Evaluate Efficacy and Safety of Masitinib in Patients With Relapse or Refractory Multiple Myeloma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01470131
Recruitment Status : Unknown
Verified December 2012 by AB Science.
Recruitment status was:  Recruiting
First Posted : November 11, 2011
Last Update Posted : December 13, 2012
Information provided by (Responsible Party):
AB Science

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Unknown
  Estimated Primary Completion Date : April 2013
  Estimated Study Completion Date : December 2014